International Journal of Infection

Published by: Kowsar

Antimicrobial Drug Resistance in Escherichia coli from Humans, and Identification of Carbapenemase-Producing E. coli in the City of Zabol, Iran

Khadije Rezaie Keikhaie 1 , Fatemeh Moshtaghi 2 , Maryam Sheykhzade Asadi 3 , Samira Seyed Nejad 3 and Gholamreza Bagheri 4 , *
Authors Information
1 Maternal Fetal Medicine, Obstetric and Gynecology, Maternal and Fetal Health Research Center, Zabol University of Medical Sciences, Zabol, IR Iran
2 Department of Biology of Basic Sciences, University of Zabol, Zabol, IR Iran
3 Department of Microbiology, Shiraz Branch, Islamic Azad University, Shiraz, IR Iran
4 Zabol Medicinal Plant Research Center, Zabol University of Medical Sciences, Zabol, IR Iran
Article information
  • International Journal of Infection: July 2018, 5 (3); e62552
  • Published Online: June 10, 2018
  • Article Type: Research Article
  • Received: October 7, 2017
  • Revised: November 11, 2017
  • Accepted: November 15, 2017
  • DOI: 10.5812/iji.62552

To Cite: Rezaie Keikhaie K, Moshtaghi F, Sheykhzade Asadi M, Seyed Nejad S, Bagheri G. Antimicrobial Drug Resistance in Escherichia coli from Humans, and Identification of Carbapenemase-Producing E. coli in the City of Zabol, Iran, Int J Infect. 2018 ; 5(3):e62552. doi: 10.5812/iji.62552.

Abstract
Copyright © 2018, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Al-Jasser AM. Extended-Spectrum Beta-Lactamases (Esbls): A Global Problem. Kuwait Med J. 2006;38(3):171-85.
  • 2. Hanson S. Jodal Urinary Tract Infection. In: Barratt TM, Avner ED, Harmon W, editors. Pediatric Nephrology. Baltimore: Williams and Wilkins; 1999. p. 835-50.
  • 3. Winberg J. Clinical Aspects Of Urinary Tract Infections. In: Holliday MA, Barrat TM, Vernier RL, editors. Pediatric nephrology. Baltimore: Williams and Wilkins; 1987. p. 626-46.
  • 4. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10(8):509-15. [PubMed: 11118930].
  • 5. Astal ZE. Increasing Ciprofloxacin Resistance Among Prevalent Urinary Tract Bacterial Isolates In The Gaza Strip. Singapore Med J. 2005;46(9):457.
  • 6. Schwaber MJ, Navon-Venezia S, Schwartz D, Carmeli Y. High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2005;49(5):2137-9. doi: 10.1128/AAC.49.5.2137-2139.2005. [PubMed: 15855548]. [PubMed Central: PMC1087677].
  • 7. Duttaroy B, Mehta S. Extended spectrum B lactamases (Esbl) in clinical isolates of Klebsiella pneumoniae and Escherichia coli. Indian J Pathol Microbiol. 2005;48(1):45-8. [PubMed: 16758790].
  • 8. Ericsson HM, Sherris JC. Antibiotic Sensitivity Testing. Report Of An International Collaborative Study. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;217:Suppl 217. [PubMed: 4325956].
  • 9. Ghadiri K, Ahmadi P, Abiri R, Saidzade SA, Babaei H, Salehi A, et al. [The MIC Study of Antibiotics Used in the Treatment of Children with Urinary Tract Infections caused by E. coli using E-test and ts Comparison with Disk Diffusion]. ZUMS Journal. 2009;17(67):89-98. Persian.
  • 10. Mohajeri P, Izadi B, Rezai M, Falahi B, Khademi H, Ebrahimi R. [Assessment Of The Frequency Of Extended Spectrum Beta Lactamases Producing Escherichia Coli Isolated From Urinary Tract Infections And Its Antibiotic Resistance Pattern In Kermanshah]. J Ardabil Uni Med Sci. 2011;11(1):86-94. Persian.
  • 11. Asadpour Rahimabadi K, Hashemitabar G, Mojtahedi A. [Antibiotic-resistance Patterns in E. coli Isolated from Patients with Urinary Tract Infection in Rasht]. J Guilan Uni Med Sci. 2016;24(96):22-9. Persian.
  • 12. Aghamahdi F, Hashemian H, Shafiei M, Akbarian Z, Rostam Nejad M, Fallah Karkan M. Etiologies And Antibiotic Resistance Patterns In Infants With Urinary Tract Infections Hospitalized In Children Medical Center, Rasht, Iran. IJN. 2013;4(2):21-5. doi: 10.22038/IJN.2013.1078.
  • 13. Abdollahi Kheirabadi S, Najafipour S, Kafilzadeh F, Abdollahi A, Jafari S, Moravej A. [Evaluation of Drug Resistance Pattern of Escherichia coli Strains Isolated from Fasa Vali-e-Asr Hospital Patients]. J Fasa Uni Med Sci. 2013;2(4):273-8. Persian.
  • 14. Mollahosseini A, Gorge Por M, Namrudi J, Moghateli M. The Study Used Antibiotic Resistance In E. coli Blood Culture Samples Patients Shahid Sadoughi Hospital In 2015. Quarterly J of the Student Res Committee. 2015;18(60):42-8.
  • 15. Sabir S, Ahmad Anjum A, Ijaz T, Asad Ali M, Rehman Khan M, Nawaz M. Isolation and Antibiotic Susceptibility of E. coli from Urinary Tract Infections In a Tertiary Care Hospital. Pak J Med Sci. 2014;30(2):389-92. [PubMed: 24772149]. [PubMed Central: PMC3999016].
  • 16. Ferdosi-Shahandashti E, Javanian M, Moradian-Kouchaksaraei M, Yeganeh B, Bijani A, Motevaseli E, et al. Resistance Patterns of Escherichia coli Causing Urinary Tract Infection. Caspian J Intern Med. 2015;6(3):148-51. [PubMed: 26644881]. [PubMed Central: PMC4650789].
  • 17. Akond MA, Alam S, Hassan SMR, Shirin M. Antibiotic Resistance of Escherichia coli Isolated from Poultry and Poultry Environment of Bangladesh. Inter J of Food Safety. 2009;11:19-23.
  • 18. Tadesse DA, Zhao S, Tong E, Ayers S, Singh A, Bartholomew MJ, et al. Antimicrobial Drug Resistance in Escherichia coli from Humans and Food Animals, United States, 1950-2002. Emerg Infect Dis. 2012;18(5):741-9. doi: 10.3201/eid1805.111153. [PubMed: 22515968]. [PubMed Central: PMC3358085].
  • 19. Chaudhary M, Payasi A. Prevalence, Genotyping of Escherichia coli and Pseudomonas aeruginosa Clinical Isolates for Oxacillinase Resistance and Mapping Susceptibility Behaviour. J Microb Biochem Technol. 2014;6(2). doi: 10.4172/1948-5948.1000123.
  • 20. Nordmann P, Poirel L. Strategies for Identification of Carbapenemase-Producing Enterobacteriaceae. J Antimicrob Chemother. 2013;68(3):487-9. doi: 10.1093/jac/dks426. [PubMed: 23104494].
  • 21. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V, et al. Identification and Screening of Carbapenemase-Producing Enterobacteriaceae. Clin Microbiol Infect. 2012;18(5):432-8. doi: 10.1111/j.1469-0691.2012.03815.x. [PubMed: 22507110].
  • 22. Rasmussen JW, Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother. 2006;57(3):373-83. doi: 10.1093/jac/dki482. [PubMed: 16446375].
  • 23. Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents. 2010;36:8-14. doi: 10.1016/s0924-8579(10)70004-2.
  • 24. Erdem H, Inan A, Altındis S, Carevic B, Askarian M, Cottle L, et al. Surveillance, Control and Management of Infections in Intensive Care Units in Southern Europe, Turkey and Iran–a Prospective Multicenter Point Prevalence Study. J Infection. 2014;68(2):131-40. doi: 10.1016/j.jinf.2013.11.001.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments